Peter O’Gorman
Mater Misericordiae Hospital(AU)Mater Misericordiae University Hospital(IE)Cancer Trials Ireland(IE)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Protein Degradation and Inhibitors, Peptidase Inhibition and Analysis, Ubiquitin and proteasome pathways, Advanced Proteomics Techniques and Applications
Most-Cited Works
- → Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial(2019)376 cited
- → High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution(2002)359 cited
- → Management of relapsed multiple myeloma: recommendations of the International Myeloma Working Group(2015)250 cited
- → Whole-Body MRI Versus PET in Assessment of Multiple Myeloma Disease Activity(2009)184 cited
- → Bone Disease in Multiple Myeloma: Pathophysiology and Management(2014)179 cited
- → Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI)(2008)